Sign in to view content

Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections

Geoffrey G. Emerson, MD, PhD, FASRS

Video
Published 2021

Related

The Conundrum of Intravitreal Injections and Use of -25 Modifier for Same-Day Office Visits
John T. Thompson, MD
Annual Meeting Talks
2021
Uncertain Benefit of Vitrectomy for Post-Injection Endophthalmitis in Age-Related Macular Degeneration
Mark R. Barakat, MD
On Demand Cases, Courses, and Papers
2017
Noninferiority of 1.7% Povidone–Iodine for Endophthalmitis Prophylaxis After Intravitreal Injections Compared With 5% Povidone–Iodine in an Office Setting
Kamal Kishore, MD, MBBS
Annual Meeting Talks
2022

Category: Socioeconomics

See more